Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer to assume Aleve marketing by year-end under Roche joint venture.

This article was originally published in The Tan Sheet

Executive Summary

BAYER TO ASSUME ALEVE MARKETING BY END OF 1996 under a 50/50 joint venture agreement with Roche announced by the companies on Sept. 16. Bayer's Morris Township, N.J.-based Consumer Care Division will handle U.S. sales and marketing of the joint venture brands, which also include Roche's Femstat 3 vaginal yeast infection treatment and four Bayer brands: Actron and Vanquish analgesics; Midol menstrual discomfort products; and Mycelex-7 yeast infection treatment.
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS086028

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel